{"name":"Peregrine Ophthalmic","slug":"peregrine-ophthalmic","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk91SWw5cmEtMzhiRXhJNmRsVnpBaWhfcXg0T0h5Szh4Tm1zSGk0V1h1emxUcVRmaVgyczdpM1ZXXzJFYVBvWXRuNGpXckd1NjJzWmU0ZVFNMmpJSFl6dTFDR0I3Zzk0VURWZmo0bGl1Zl9hbHhOY1k3elhSNXlXM09HeDlMNk5mSFlZajQxSDctOGl5c0ZtYm9fbnZ6aEU?oc=5","date":"2026-04-03","type":"earnings","source":"openPR.com","summary":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 - openPR.com","headline":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOX3NVWEhXLVYybUFPZTN6Tlp4TFJHTFRPOHJEenROZTRTREFzcmc3d0JOVHByTktJVExCbkQ5RGdyMEdsdjhCY01qRmgtRzdSaGdlYkYwb0txWUdPaVdGZkJ3d082d29HcXZsY0RHVG9FY3BORTZnQ2lVektRMGZhbU5SOVFya0lHZTJHUWtWSThvWVBEaXppblpYQWpGWXFY?oc=5","date":"2025-12-01","type":"deal","source":"Legal Desire Media and Insights","summary":"Mayer Brown advises Inspirit Capital on the merger of mthree and Peregrine - Legal Desire Media and Insights","headline":"Mayer Brown advises Inspirit Capital on the merger of mthree and Peregrine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNeGh0c3VweFFnWmVnRkFPQ3JtTnFRWXBMbFYxdVdvR0ltWlBqV3BHZnczVFZfaVc1V0NBY3l3WDU3dW55TkZhQTVtV082RFFjRU1MYlEzcFBnN1NiNUJLa2U3empwZ3NVZklCb1ZsY0RWQ2U1WFRBSktRZXljWFFLWkQtQTNQVUNHY2puQkhVYUdUMWhTQzhYQXFJbFdJMEhIMkVsVkZ0ZldPa2cwMWdEOW1IQUN4N2lCMXg3bUJSTXRzWV9mb1FpaklQMGphUmVxNWtlRzRiUmN0UjZUd0VRalBfaDRiOE5aWnhucTVsaWdCamdSUEQ5SzBWYw?oc=5","date":"2025-05-15","type":"pipeline","source":"GlobeNewswire","summary":"Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire","headline":"Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQMHhfSGI1a3NjMkNsRC1ZdkRNUzJnS0FnMkhZbFBiRWF2Ykp0cHlVQ3IyZVRsZWNQQjNEaW5ESUd5V0ktU3NYYnI4NHAxT0tDLVFQZ0dDMlhyekNqZzI4RnRhX3FXV3VnX1VFODIwMkRvdUwxMEJqRlBjNnkwRktlODhwSEJOWEVVaERzXzlPTGdpSDNITmpFWXdjYldwUHkwWXVldjZXSkp6N3lZWC1LOEtqOGJRY05NdU52V1JFejhKX1BFS3NXRG1wd0NnckxyNmdIRWxoUGVnalJOeWp3Rl9TaDNHYThTOHc?oc=5","date":"2025-03-25","type":"pipeline","source":"PR Newswire","summary":"ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight - PR Newswire","headline":"ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxONzJwRzBpN1dGQ1h1QkRLdEFDQnRrcTJhMUkwSTJRdk9uZWJkVUZOd2VNel8tTWlJYzZkSzdJSG9nRXRuZFpkVFpEV1RKMDBvTWlkNnRaN3BzVUU5SWdZZDVwc1djWWhEaVhPRjlxWS15RDRJbm9hS29hQllqQktObGtUTDZ6OHlRQ2F4ZGlNQzFRUlpNakd2MkdiU244N3hLX3lka3FHS3VoTlVtbzJ2LXk2UHJ0ckZ5VjdGUi1MSUFRaU5YX2kxb2tOUnJoUFItM256NTFaaHhRSlpFRjdNVWE1eEZmY3RzdW5LZmZGcmI4dEVaNFlWcmZFQ3RXRVhfaGctMVhYTm9pdVMyaUx4ZC1feDh1SGk2czRLRUJzaDQydWVlWUdQUFR6bzJ5c09PaUtCWFNoQQ?oc=5","date":"2025-02-26","type":"pipeline","source":"GlobeNewswire","summary":"DURYSTA’s Market Potential Across the 7MM is Set to Soar - GlobeNewswire","headline":"DURYSTA’s Market Potential Across the 7MM is Set to Soar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOcTFsdWh2ejBfaDNLQ1RrdmxPUTFpVkxaUXhLRHB0SDJBc2R5ZkUyaTNhMWp3OGJJZVB5b3pheUhVNTFqVVl5TVVlZml5Rk5qSHBMelVxV1BORjVySEJrYkxPRVk4SU1QaC1sNno2M2JoU0R5UXFyTDFCcWtTa0F5RF90aXZqeDNOT2dudWVGbkoweEdaZnpsYmRNeGl1aVJSR1ZHczJ4TlphWkRlcU1DbEU0V1RjWHBDQmVoaF9zRzdSZXc4S0RWQXozRkVmNEY0U2Q0eUIybWs4TmZrMnAxbFdocDAyNkZYRjQxejN0SEVqVGlZUXVVbFlLUHZoSG9OTUE?oc=5","date":"2023-05-18","type":"trial","source":"PR Newswire","summary":"Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for the Market Entry - PR Newswire","headline":"Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for the Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNWTFxeUM4TnJVeThmNEhuZnItakVxMm1Fb21YYnRZQUktTDAyTk5GWEdCalJlT054ZVhoU1p4SVhpSVdETVdzcDhxZmFVdExYdW1McXVWU0xSODI4QTRHdlpLMGxXWmNMdHNSb09XOUliOFdOcFZyNnA3YWdaMjY0Yi1mc0t5bnVZTzRCWjZMRUtrcDJLQzZhcjFHSmlDZTREdjFiZi1lQ1paSktjLTZuQ1FMZF9QYWhlQlZGSzhmbmI?oc=5","date":"2021-06-08","type":"pipeline","source":"Dove Medical Press","summary":"OPTH - Dove Medical Press","headline":"OPTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQVEUtdnMxb21ZVVlCdTJIT2FTOWxadDVIVlFFV0EzM0dzLVUxcU5CU29HcWJqTzExYmdnZEFxdXRWaTlUeFotTWZpN0VmcnZuTUVnQWs4d0hUUDA2RWFKMkdkYVF3eWpJV3ZYY3ptWTZDY1dadnRqRVVOZUlsVFBmRFBQWFBiZmpGR3laTXZjU1RUSDBCWV9yNHZjTGNVQQ?oc=5","date":"2020-11-11","type":"pipeline","source":"NoCamels","summary":"Peregrine Ventures Launches New $300M Fund For Life Science Startups - NoCamels","headline":"Peregrine Ventures Launches New $300M Fund For Life Science Startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBIanlHa2VTQ1dEZTVFWUlYX2ZJRGR2MVFZYWtkQ2ZsTFAwV1pjTEQ4U2laZm9WVHUwR3hyejVzRkE5dlVVNElDVnExamRxQUlMa05VOVFDd05PdmFleUl1MTVjbVVadmQzaVp3azNWaDVXc216eXhvdTVn0gF_QVVfeXFMTTZ2VFFjMGY2cndfQmJ2MTE2dVRaRHdJLUxtRkJlYkFxWHRUVkpNR3ByeloyS1N6ajFBV1RBWHVDTnlzRFJqeko1U1Rfbk9JUUJDY0x3dEtHeHhxX2hlZUxqWW1BZlZER2RmQmZGaW1QM3c4ZkxGYWVOR0lpcWtoOA?oc=5","date":"2015-03-09","type":"pipeline","source":"Prestige Hong Kong","summary":"The Eye Specialist: Tina Wong - Prestige Hong Kong","headline":"The Eye Specialist: Tina Wong","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}